1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Central America Pharmaceuticals and Healthcare Report Q1 2016

Central America Pharmaceuticals and Healthcare Report Q1 2016

  • November 2015
  • -
  • Business Monitor International
  • -
  • 63 pages

BMI View

: Legislative and regulatory improvements to the Central American healthcare system willfurther strengthen sector coordination, enhancing medical efficiencies and treatments over the long-term.The region's ageing population and dependence on pharmaceutical imports will increase foreign investmentappeal as public health provision grows.

Headline Expenditure Projections

- Pharmaceuticals: USD3.7bn in 2014 to USD3.9bn in 2015; +4.6%. Our forecast has been maintainedsince Q115.
- Healthcare: USD16.5bn in 2014 to USD17.4bn in 2015; +4.9%. Our forecast has been reviseddownwards since Q415 due to revised macroeconomic data.

Table Of Contents

Central America Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
SWOT 9
SWOT 9
Industry Forecast 10
Pharmaceutical Market Forecast 10
Table: Central America Pharmaceutical Sales, Historic Data And Forecasts 12
Guatemala 12
Table: Guatemala Pharmaceutical Sales Forecasts 12
Costa Rica 12
Table: Costa Rica Pharmaceutical Sales Forecasts 13
El Salvador 13
Table: El Salvador Pharmaceutical Sales Forecasts 13
Honduras 13
Table: Honduras Pharmaceutical Sales Forecasts 14
Panama 14
Table: Panama Pharmaceutical Sales Forecasts 14
Nicaragua 14
Table: Nicaragua Pharmaceutical Sales Forecasts 15
Healthcare Market Forecast 16
Table: Central America Healthcare Expenditure Trends, Historical Data And Forecasts 18
Guatemala 18
Table: Guatemala Healthcare Expenditure Forecasts 18
Costa Rica 19
Table: Costa Rica Healthcare Expenditure Forecasts 19
El Salvador 19
Table: El Salvador Healthcare Expenditure Forecasts 19
Panama 20
Table: Panama Healthcare Expenditure Forecasts 20
Honduras 20
Table: Honduras Healthcare Expenditure Forecasts 21
Nicaragua 21
Table: Nicaragua Healthcare Expenditure Forecasts 21
Pharmaceutical Trade Forecast 22
Guatemala 24
Table: Guatemala Pharmaceutical Trade Data And Forecasts (USDmn) 24
Costa Rica 24
Table: Costa Rica Pharmaceutical Trade Data And Forecasts (USDmn) 25
El Salvador 25
Table: El Salvador Pharmaceutical Trade Data And Forecasts (USDmn) 25
Panama 25
Table: Panama Pharmaceutical Trade Data And Forecasts (USDmn) 26
Honduras 26
Table: Honduras Pharmaceutical Trade Data And Forecasts (USDmn) 26
Nicaragua 27
Table: Nicaragua Pharmaceutical Trade Data And Forecasts (USDmn) 27
Industry Risk Reward Index 28
Americas Risk/Reward Index 28
Central America Risk/Reward Index 35
Rewards 35
Risks 35
Regulatory Review 37
Intellectual Property Issues 37
Costa Rica 38
El Salvador 39
Honduras 39
Nicaragua 40
Guatemala 40
Market Overview 41
Healthcare Sector - Country Specific Updates 41
Guatemala 41
Costa Rica 41
El Salvador 44
Panama 45
Honduras 47
Nicaragua 47
Clinical Trials 48
Epidemiology 50
Competitive Landscape 52
Research Based-Industry 52
Generic Drugmakers 52
Company Profile 53
Ancalmo Internacional 53
Donovan Werke 55
Glossary 57
Methodology 59
Pharmaceutical Expenditure Forecast Model 59
Healthcare Expenditure Forecast Model 59
Notes On Methodology 60
Risk/Reward Index Methodology 61
Index Overview 62
Table: Pharmaceutical Risk/Reward Index Indicators 62
Indicator Weightings 63

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.